DelphX Announces Closing of Non-Brokered Unit Private Placement

Rhea-AI Summary

DelphX (OTCQB: DPXCF; TSXV: DELX) closed a non-brokered unit private placement announced Nov 27, 2025, issuing 2,800,000 units at C$0.04 per unit for gross proceeds of C$112,000. Each unit comprises one common share and one warrant.

Each warrant allows purchase of one common share at $0.07 for two years from issuance. Completion remains subject to TSX Venture Exchange approval. Securities are subject to a four-month plus one day hold period. DelphX intends to use net proceeds for working capital and corporate overhead.

Positive

• Gross proceeds C$112,000 raised for working capital
• Units include common share plus one warrant, offering structured investor incentive

Negative

• 2,800,000 warrants exercisable at $0.07 for two years create potential dilution
• Offering completion is subject to TSXV approval, so issuance is not final
• C$112,000 gross proceeds represent a relatively small funding amount

Toronto, Ontario--(Newsfile Corp. - December 2, 2025) - DelphX Capital Markets Inc. (TSXV: DELX) (OTCQB: DPXCF) ("DelphX"), a leader in the development of new classes of structured products, announces that it has closed its non-brokered private placement previously announced on November 27, 2025, issuing 2,800,000 units (the "Units") at a subscription price of C$0.04 per Unit, for gross proceeds of C$112,000 ("the Offering"). Each Unit consists of one common share ("Common Share") and one Common Share purchase warrant ("Warrant"). Each Warrant entitles the holder to purchase one Common Share at a price of $0.07, for a period of two years from the date of issuance.

Completion of the Offering is subject to the approval of the TSX Venture Exchange. The securities issued pursuant to the Offering will be subject to a hold period of four months plus one day from the date of issuance.

DelphX intends to use the net proceeds from the Offering in connection with working capital/corporate overhead.

About DelphX Capital Markets Inc.

DelphX is a technology and financial services company focused on developing and distributing the next generation of structured products. Through its special purpose vehicle Quantem LLC, the Company enables broker dealers to offer new private placement securities that provide for both fixed income and cryptocurrency solutions. The new DelphX securities will enable dealers and their qualified institutional investors (QIBs) accounts to competitively structure, sell and make markets in:

• Collateralized put options (CPOs) that provide secured rating downgrade protection for underlying corporate bonds and/or protection from losses in cryptocurrency holdings;

• Collateralized reference notes (CRNs) that enable investors to take on a capped rating downgrade and/or cryptocurrency loss exposure of an underlying security or cryptocurrency in exchange for attractive returns.

All CPOs and CRNs are fully collateralized and held in custody by US Bank. CPOs and CRNs are proprietary products created and owned by DelphX Capital Markets.

For more information about DelphX, please visit www.delphx.com

George Wentworth, General Manager
DelphX Capital Markets Inc.
george.wentworth@delphx.com
(718) 509-2160

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/276707

FAQ

What exactly did DelphX (DPXCF) issue in the December 2, 2025 private placement?

DelphX issued 2,800,000 units at C$0.04 each; each unit includes one common share and one warrant.

How large was the DelphX (DPXCF) financing closed Dec 2, 2025?

The offering raised gross proceeds of C$112,000.

What are the warrant terms from DelphX's Dec 2, 2025 placement (DPXCF)?

Each warrant entitles the holder to buy one common share at $0.07 for two years from issuance.

Is the DelphX (DPXCF) private placement final and tradable now?

Completion is subject to TSX Venture Exchange approval, and issued securities have a four-month-plus-one-day hold period.

How will DelphX (DPXCF) use the net proceeds from the offering?

DelphX intends to use net proceeds for working capital and corporate overhead.